Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Reviews

Systematic Review and Meta-study Synthesis of Qualitative Studies Evaluating Facilitators and Barriers to Participation in Colorectal Cancer Screening

Gladys N. Honein-AbouHaidar, Monika Kastner, Vincent Vuong, Laure Perrier, Corinne Daly, Linda Rabeneck, Sharon Straus and Nancy N. Baxter
Gladys N. Honein-AbouHaidar
1Department of Surgery, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Monika Kastner
2Knowledge Translation Program, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Canada.
3Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vincent Vuong
1Department of Surgery, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laure Perrier
2Knowledge Translation Program, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Corinne Daly
1Department of Surgery, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Linda Rabeneck
4Cancer Care Ontario, Toronto, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sharon Straus
2Knowledge Translation Program, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Canada.
5Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nancy N. Baxter
1Department of Surgery, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Canada.
5Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: baxtern@smh.ca
DOI: 10.1158/1055-9965.EPI-15-0990 Published June 2016
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Additional Files
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Study selection PRISMA flow chart.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    A novel conceptual framework of factors influencing the decision to participate in colorectal cancer screening.

Tables

  • Figures
  • Additional Files
  • Table 1.

    Themes, according to facilitators and barriers, associated with participation in colorectal cancer screening, with exemplary quotes

    ThemeFactorExemplary quote
    Facilitators
    AwarenessAppropriate awareness of CRC screening and purpose of screening are pre-requisites for CRC screening participation (9–11, 13, 31, 34–40, 52, 57, 60, 67, 68, 75, 78, 80, 87, 106, 108)“If the cancer was found at the first stage, of course, the cancer will be cured more easily than the cancer found at the third or fourth stage… So when the doctor asked me to have a [FOBT], I did it right away” (11)
    Positive attitudes towards CRC screening testsPositive attitudes and preferences for CRC screening test (13, 18, 31, 34, 35, 37, 38, 40–42, 46, 56, 57, 63, 66, 77, 80, 82, 83, 85, 88, 89, 93, 95, 106, 124–126)“At least [its] not painful…it's in privacy of your own home” (41)
    Motivation for screeningDesire to stay healthy and peace of mind (10, 19, 36, 48, 54–57, 68, 73, 80, 86, 88, 90)“Put your mind at ease that you're not effected by whatever they are screening for” (54).
    Having a close individual affected by CRC (10, 13, 52, 54, 55, 58–62, 74, 75, 121)“If somebody you know has suffered with whatever then it makes you think ‘should I be tested for this, should I do that?” (58)
    Spouse as motivators (13, 31, 34, 57, 58, 61–66)“Well simply that wives frequently provide guidance in these matters to their husbands.” (61)
    Barriers
    Lack of awarenessLack of awareness of CRC screening (9, 10, 13, 16–18, 20, 31, 34, 36–38, 40–44, 47–50, 63, 65, 69, 71, 72, 78–80, 82, 83, 90, 107)“I have never heard of colorectal cancer screening. I was never recommended to do it and nobody has ever told me it's available. If I had known that there are various methods of colorectal cancer screening, I would you have gone for it or at least find out more about it” (82)
    Symptom-driven testing (11, 13, 17, 18, 31, 36–38, 41, 44, 46, 48, 53–56, 58, 59, 62, 68, 71, 74, 75, 77, 78, 80, 82, 84, 86, 90, 97, 98, 100, 102)“Nothing wrong with me. Why should I do that [screening test]?” (102)
    Negative views of cancerFear of cancer, screening results and treatment (10, 11, 13, 17, 31, 34–36, 41, 42, 44–46, 48–50, 52–58, 60, 65, 68–70, 74, 75, 77, 82–87, 90, 93, 96, 106, 121, 127–129)“…you are afraid that the doctor is going to tell you that you have cancer, so a lot of times you don't go because you are scared” (49)
    Cancer is fatal and no screening can stop it (9, 10, 31, 34, 36, 38, 45–47, 49, 52, 53, 55, 58, 63, 65, 68, 72, 74, 82, 83, 87, 98, 108, 127)“When I hear about cancer, the first thing I think is death” (53)
    Negative attitudes towards CRC screening testsNegative attitudes towards CRC screening tests (12, 17, 18, 31, 38, 40–42, 45–48, 50, 52, 55, 66, 68–71, 73–75, 82, 84, 86, 88, 90, 102, 105–107, 124, 126)“I think they're [colonoscopy, flexible sigmoidoscopy], you know, invasive and physically unpleasant” (40)
    Embarrassment (13, 33, 41, 42, 44, 45, 48, 49, 54, 55, 58, 60, 63, 65, 67, 72, 73, 80, 105, 124, 127)“I think what happens is that it is something intimate and embarrassing. – Ashamed. – More intimate than a pap smear or mammography” (13)
    Questioning efficacy of the test (9, 18, 19, 31, 34, 41, 42, 49, 56, 72, 82, 88, 89)“[Every] six months you go see your doctor and he said you got no cancer, next six month you see your doctor he says you are going to die…” (56)
    Lack of motivationOther health concerns deterred from seeking screening (13, 18, 35, 36, 43, 45, 50, 55, 56, 90, 91)“I don't think too much about [CRC risk]… I worry more, I think, that I might get it [cancer] in the breast than anywhere else. Cause I've had lumps there” (90)
    Competing life demands deterred from seeking screening (13, 17, 20, 36, 39, 43, 45, 47, 48, 50, 54, 60, 82)“I've been busy with work and looking after the family. When I go home, I'm so tired I can't take out extra time to go down to the hospital. And the queue's really long in hospital, right?” (82)
    Scheduling challenges (34, 50, 70, 76, 85, 86, 92, 93)“It was more of a scheduling problem with the endoscopy clinic” (86)
    Cultural, gender, socioeconomicNatural remedies conquer CRC (11, 54, 59, 68, 69)“Back home we have a lot of good home remedies. These remedies can cure most anything. I have a good remedy for stomach aches. Whenever I get a cold I boil ‘ti bonm’ and drink it hot and right away my stomach feels better” (69)
    Ethnic food protect from CRC (18, 53, 59, 60)“We are different because our diet is predominantly fibre-based… so maybe there isn't [CRC] a lot in our community” (80)
    Wellness visits are not part of the culture (13, 63, 69, 72, 73, 84)“In our culture we don't do these kinds of tests unless vital” (73)
    CRC screening tests are offensive to masculinity and manhood (13, 16, 31, 36, 40, 44, 45, 57, 64, 65, 79–81, 95, 127)“a threat to masculinity: “an attack on your armour” (80)
    Females perceived CRC as a male disease (31, 33, 34, 36, 65, 80, 90, 105–107)“I thought it [CRC] was a man's disease” (106)
    Taking time off was not possible (17, 42, 63, 66, 84, 86, 96)“The time when the office or hospital is operand is not a good time for me. I work during the weekday and cannot get a day off” (96)
    Transportation and finding an escort was a challenge (36, 84, 85, 88, 92, 96)“We do not have cars or a second car, and there is no public transportation in our area so it is not as easy to go see the doctor.” (85)
    Low health literacy (11, 18, 31, 36, 38, 40, 45, 46, 63, 71, 89, 93, 106)“Then we go into as to the polyps and the lumps and so forth and it seems to be oriented a little more for some of us familiar with this type of, well with these names and so forth…” (71)
    Language barriers (9–11, 49, 72, 80, 92, 97, 99)“[Providers from another clinic] just told us to take [the FOBT instructions] back and read it ourselves… You know Chinese—we don't understand English that much. So I just threw it aside…I did not do it because I don't quite understand” (11)
    • Abbreviation: CRC, colorectal cancer.

  • Table 2.

    Modifiers of facilitators and barriers associated with participation in colorectal cancer screening, with exemplary quotes

    ModifiersExemplary quote
    FacilitatorsPublic education raises awareness and addresses misconceptions and unrealistic fears (10, 18, 31, 37, 65, 86)“The more it's in the media, the more socially acceptable it is to talk about it [CRC]” (31)
    PCP recommendation motivate individuals to get screened (10, 11, 18, 19, 31, 34, 36–38, 43, 54–56, 60, 65, 68, 71, 75, 121)“If my doctor says to… I'd go ahead and have one done.” (34)
    Interpersonal communication with PCP (12, 48, 63, 69, 78, 81, 90, 97, 108, 124)“Talking to the patient in the language the patient can understand…that's the key.” (81)
    Friends, family, and partners are important source of information and emotional support (18, 38, 49, 61, 81, 128)“If she [spouse] says, ‘Ah, I'm not going to do it’, I say, ‘Ah, neither am I', but if she says, ‘I'm going to do it’, I say, ‘Ah, me too” (13)
    BarriersLittle public education about CRC compared with other cancers (13, 17, 19, 31, 43–45, 59, 64, 65, 69, 80, 85, 99, 101, 102, 107)“I couldn't tell you what could cause colon cancer because they don't talk much about this subject. Talk about other types of cancer is more common” (44)
    Lack of physician's recommendation and approach was a powerful deterrent for CRC screening participation (9, 16, 18, 20, 31, 33, 36, 42, 45, 52, 59, 65, 70, 84, 90, 92, 99, 130)“My doctor never said anything to me about it. If he wanted me to have it, wouldn't he say something?” (65)
    Friends, family, and kin accounts of a negative experience (31, 45, 60, 61, 70, 75–77) (36)“I know people who found out they had cancer and they died in 2 months” (36)
    PCP inadequate explanation (47, 67, 81, 90, 104, 126, 131)“You can go all high falutin' [sic] and talk about prostate-specific antigens, and if the patient doesn't understand what that means, he's going to get frightened.” (81)
    • Abbreviations: CRC, colorectal cancer; PCP, primary care physician.

Additional Files

  • Figures
  • Tables
  • Supplementary Data

    • Supplementary Tables S1-S3 - Supplementary tables include: details of search strategy (S1), characteristics of included studies (S2), and quality assessment of included studies (S3).
PreviousNext
Back to top
Cancer Epidemiology Biomarkers & Prevention: 25 (6)
June 2016
Volume 25, Issue 6
  • Table of Contents
  • Table of Contents (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Systematic Review and Meta-study Synthesis of Qualitative Studies Evaluating Facilitators and Barriers to Participation in Colorectal Cancer Screening
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Systematic Review and Meta-study Synthesis of Qualitative Studies Evaluating Facilitators and Barriers to Participation in Colorectal Cancer Screening
Gladys N. Honein-AbouHaidar, Monika Kastner, Vincent Vuong, Laure Perrier, Corinne Daly, Linda Rabeneck, Sharon Straus and Nancy N. Baxter
Cancer Epidemiol Biomarkers Prev June 1 2016 (25) (6) 907-917; DOI: 10.1158/1055-9965.EPI-15-0990

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Systematic Review and Meta-study Synthesis of Qualitative Studies Evaluating Facilitators and Barriers to Participation in Colorectal Cancer Screening
Gladys N. Honein-AbouHaidar, Monika Kastner, Vincent Vuong, Laure Perrier, Corinne Daly, Linda Rabeneck, Sharon Straus and Nancy N. Baxter
Cancer Epidemiol Biomarkers Prev June 1 2016 (25) (6) 907-917; DOI: 10.1158/1055-9965.EPI-15-0990
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Conclusion
    • Disclosure of Potential Conflicts of Interest
    • Grant Support
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Environmental Exposures and Non-Hodgkin Lymphoma
  • The Human Microbiome and Cancer Risk
  • U.S. Cervical Cancer Screening Preferences Systematic Review
Show more Reviews
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement